Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financial Results on August 5, 2024
Tactile Systems Technology, Inc. (Nasdaq: TCMD), operating as Tactile Medical, has announced the release date for its second quarter fiscal year 2024 financial results. The results will be disclosed after market close on Monday, August 5, 2024. Following the release, management will host a conference call with a Q&A session at 5:00 p.m. Eastern Time on the same day.
Interested parties can participate in the call by dialing 877-407-3088 (201-389-0927 for international callers) and using the access code 13745955. A live webcast will be available on the company's investor relations website. For those unable to attend, a replay will be accessible for two weeks.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), operante come Tactile Medical, ha annunciato la data di rilascio dei suoi risultati finanziari del secondo trimestre dell'anno fiscale 2024. I risultati saranno resi noti dopo la chiusura del mercato lunedì 5 agosto 2024. Dopo il rilascio, il management ospiterà una call congiunta con sessione di domande e risposte alle 17:00 ora orientale nello stesso giorno.
Le parti interessate possono partecipare alla chiamata componendo 877-407-3088 (201-389-0927 per chiamate internazionali) e utilizzando il codice di accesso 13745955. Una diretta streaming sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda. Per coloro che non possono partecipare, una registrazione sarà accessibile per due settimane.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), operando como Tactile Medical, ha anunciado la fecha de lanzamiento de sus resultados financieros del segundo trimestre del año fiscal 2024. Los resultados se divulgarán después del cierre del mercado el lunes 5 de agosto de 2024. Después del lanzamiento, la dirección llevará a cabo una conferencia telefónica con una sesión de preguntas y respuestas a las 5:00 p.m. hora del Este el mismo día.
Las partes interesadas pueden participar en la llamada marcando 877-407-3088 (201-389-0927 para llamadas internacionales) y utilizando el código de acceso 13745955. Se ofrecerá una transmisión en vivo en el sitio web de relaciones con los inversores de la compañía. Para aquellos que no puedan asistir, una grabación estará disponible durante dos semanas.
Tactile Systems Technology, Inc. (Nasdaq: TCMD)는 Tactile Medical로 운영되며 2024 회계연도 2분기 재무 실적 발표 날짜를 발표했습니다. 결과는 2024년 8월 5일 월요일, 시장 마감 후 공개될 예정입니다. 발표 후, 경영진은 같은 날 동부 시간 기준 오후 5시에 Q&A 세션이 포함된 전화 회의를 개최할 것입니다.
관심 있는 분들은 877-407-3088 (국제 전화를 위한 201-389-0927)로 전화하여 액세스 코드 13745955를 사용하여 회의에 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트가 제공됩니다. 참석하지 못하는 분들은 2주간 재생을 이용할 수 있습니다.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), opérant sous le nom de Tactile Medical, a annoncé la date de publication de ses résultats financiers du deuxième trimestre de l'exercice 2024. Les résultats seront divulgués après la clôture des marchés, le lundi 5 août 2024. Suite à la publication, la direction animera une conférence téléphonique avec une session de questions-réponses à 17h00 heure de l'Est le même jour.
Les parties intéressées peuvent participer à l'appel en composant le 877-407-3088 (201-389-0927 pour les appels internationaux) et en utilisant le code d'accès 13745955. Un webinaire en direct sera disponible sur le site Web des relations investisseurs de l'entreprise. Pour ceux qui ne peuvent pas assister, un enregistrement sera accessible pendant deux semaines.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), das als Tactile Medical agiert, hat das Veröffentlichungsdatum seiner Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2024 bekannt gegeben. Die Ergebnisse werden nach Marktschluss am Montag, den 5. August 2024 veröffentlicht. Nach der Veröffentlichung wird das Management eine Konferenzschaltung mit einer Q&A-Session um 17:00 Uhr Eastern Time am selben Tag abhalten.
Interessierte Parteien können an dem Anruf teilnehmen, indem sie 877-407-3088 (201-389-0927 für internationale Anrufer) wählen und den Zugangscode 13745955 verwenden. Ein Live-Streaming wird auf der Website für Investor Relations des Unternehmens verfügbar sein. Für diejenigen, die nicht teilnehmen können, wird eine Wiederholung für zwei Wochen zugänglich sein.
- None.
- None.
MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2024 financial results will be released after the market closes on Monday, August 5, 2024.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 5, 2024, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13745955. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13745955. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When will Tactile Medical (TCMD) release its Q2 2024 financial results?
What time is Tactile Medical's (TCMD) Q2 2024 earnings conference call?
How can investors participate in Tactile Medical's (TCMD) Q2 2024 earnings call?